Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare database-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare database

Published:2024-09 Issue: Volume:209 Page:114261
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Mortier Laurent,Blom Astrid,van Hille Benoît,Samimi Mahtab,Luciani Laura,Cahuzac Capucine,Robert Caroline,Quereux Gaelle,Maubec Eve,Miotti Hakima,Maillard Cathy,Aubin François,Lenormand Cédric,Solbes Marie-Noëlle,Joly Pascal,Kachaner Isabelle,Lebbé Céleste,Dutriaux Caroline,Saiag Philippe

Funder

Merck KGaA

Publisher

Elsevier BV

Reference17 articles.

1. Merkel cell carcinoma;Becker;Nat Rev Dis Prim,2017

2. Patterns of distant metastases in 215 Merkel cell carcinoma patients: implications for prognosis and surveillance;Lewis;Cancer Med,2020

3. Merkel cell carcinoma in France: a registries-based, comprehensive epidemiological survey;Fondain;J Eur Acad Dermatol Venereol JEADV,2018

4. Epidemiology of Merkel cell carcinoma. A population-based study from 1985 to 2013, in northeastern of France;Kieny;Int J Cancer,2019

5. Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe;Becker;Oncotarget,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP